{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:55:35Z","timestamp":1790870135799,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC3506100"],"award-info":[{"award-number":["2024YFC3506100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC3506101"],"award-info":[{"award-number":["2024YFC3506101"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271309"],"award-info":[{"award-number":["32271309"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tips.2026.08.005","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:31:34Z","timestamp":1789417894000},"page":"1171-1185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Midnolin-directed protein degradation beyond ubiquitin"],"prefix":"10.1016","volume":"47","author":[{"given":"Yuwei","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinhao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0197-7617","authenticated-orcid":false,"given":"Yanli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2026.08.005_bb0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2026.08.005_bb0010","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.tibs.2024.12.006","article-title":"Routes to molecular glue degrader discovery","volume":"50","author":"Liu","year":"2025","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.tips.2026.08.005_bb0015","doi-asserted-by":"crossref","DOI":"10.1126\/science.adh5021","article-title":"The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation","volume":"381","author":"Gu","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.tips.2026.08.005_bb0020","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.molcel.2025.05.030","article-title":"Structural basis for the midnolin-proteasome pathway and its role in suppressing myeloma","volume":"85","author":"Nardone","year":"2025","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tips.2026.08.005_bb0025","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2505345122","article-title":"Structural insights into the ubiquitin-independent midnolin-proteasome pathway","volume":"122","author":"Peddada","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2026.08.005_bb0030","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1038\/s41467-026-71002-0","article-title":"Structural dynamics of the midnolin-proteasome during ubiquitin-independent substrate turnover","volume":"17","author":"Zhu","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.08.005_bb0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/procel\/pwaf069","article-title":"Structure-based engineering of the midnolin-proteasome pathway for targeted protein degradation","volume":"17","author":"Wang","year":"2026","journal-title":"Protein Cell"},{"key":"10.1016\/j.tips.2026.08.005_bb0040","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2520128123","article-title":"Targeted degradation of c-Myc through the midnolin-proteasome pathway","volume":"123","author":"Zhao","year":"2026","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2026.08.005_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2026.151725","article-title":"Midnolin: a ubiquitin-independent proteasome adapter in development, neurodegeneration, and cancer","volume":"358","author":"Xu","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.tips.2026.08.005_bb0050","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3724\/abbs.2026002","article-title":"Biochemical and structural studies of the midnolin Catch domain bound with both wild-type and mutant IRF4 peptides reveal the molecular basis for its broad substrate specificity","volume":"58","author":"Zhong","year":"2026","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.tips.2026.08.005_bb0055","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.tibs.2025.07.009","article-title":"E3 ubiquitin ligases in signaling, disease, and therapeutics","volume":"50","author":"Ebadi","year":"2025","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.tips.2026.08.005_bb0060","doi-asserted-by":"crossref","first-page":"15885","DOI":"10.1007\/s12035-025-05203-x","article-title":"Memory-associated immediate early genes: roles in synaptic function, memory processes, and neurological diseases","volume":"62","author":"Khan","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tips.2026.08.005_bb0065","doi-asserted-by":"crossref","first-page":"11962","DOI":"10.1021\/jacs.5c22099","article-title":"Multiplexed photo-cross-linking reveals comprehensive midnolin interactome: insights into ubiquitin-independent degradation and functional diversity","volume":"148","author":"Xu","year":"2026","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.tips.2026.08.005_bb0070","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.3390\/cancers14061421","article-title":"Midnolin regulates liver cancer cell growth in vitro and in vivo","volume":"14","author":"Kweon","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tips.2026.08.005_bb0075","doi-asserted-by":"crossref","first-page":"G147","DOI":"10.1152\/ajpgi.00011.2023","article-title":"Heterozygous midnolin knockout attenuates severity of nonalcoholic fatty liver disease in mice fed a Western-style diet high in fat, cholesterol, and fructose","volume":"325","author":"Kweon","year":"2023","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tips.2026.08.005_bb0080","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70472","article-title":"Midnolin correlates with anti-tumour immunity and promotes liver cancer progression through \u03b2-catenin","volume":"29","author":"Huang","year":"2025","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.tips.2026.08.005_bb0085","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/biomedicines13020276","article-title":"Comprehensive analysis reveals midnolin as a potential prognostic, therapeutic, and immunological cancer biomarker","volume":"13","author":"Zhang","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.tips.2026.08.005_bb0090","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20232132","article-title":"Viable mutations of mouse midnolin suppress B cell malignancies","volume":"221","author":"Zhong","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tips.2026.08.005_bb0095","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/10985549.2024.2399358","article-title":"Midnolin, a genetic risk factor for Parkinson\u2019s disease, promotes neurite outgrowth accompanied by early growth response 1 activation in PC12 cells","volume":"44","author":"Chiba","year":"2024","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tips.2026.08.005_bb0100","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00366-25","article-title":"Midnolin inhibits coronavirus proliferation by degrading viral proteins","volume":"99","author":"Wang","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.tips.2026.08.005_bb0105","article-title":"Midnolin ubiquitination is required for its proteasome-mediated degradation","volume":"6","author":"He","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.tips.2026.08.005_bb0110","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3724\/abbs.2025232","article-title":"RNF126 writes a non-canonical ubiquitin code on midnolin to tune protein stability","volume":"58","author":"Yang","year":"2026","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.tips.2026.08.005_bb0115","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.trecan.2026.05.001","article-title":"\u03b2-catenin at the crossroads of cancer and neurodevelopment","volume":"12","author":"Nunes-Xavier","year":"2026","journal-title":"Trends Cancer"},{"key":"10.1016\/j.tips.2026.08.005_bb0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene\u2014the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tips.2026.08.005_bb0125","doi-asserted-by":"crossref","first-page":"9334","DOI":"10.1021\/jacs.3c02619","article-title":"c-Myc-targeting PROTAC based on a TNA-DNA bivalent binder for combination therapy of triple-negative breast cancer","volume":"145","author":"Li","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.tips.2026.08.005_bb0130","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1021\/acschembio.4c00864","article-title":"MYC-targeting PROTACs lead to bimodal degradation and N-terminal truncation","volume":"20","author":"Boyd","year":"2025","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.tips.2026.08.005_bb0135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41467-023-44237-4","article-title":"DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance","volume":"15","author":"Schr\u00f6der","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.08.005_bb0140","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41589-022-01177-2","article-title":"Functional E3 ligase hotspots and resistance mechanisms to small-molecule degraders","volume":"19","author":"Hanzl","year":"2023","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tips.2026.08.005_bb0145","doi-asserted-by":"crossref","first-page":"10183","DOI":"10.1021\/acs.jmedchem.2c00691","article-title":"Targeting undruggable transcription factors with PROTACs: advances and perspectives","volume":"65","author":"Li","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2026.08.005_bb0150","article-title":"Structure-based design of bicyclic helical peptides that target the oncogene \u03b2-catenin","volume":"63","author":"Yeste-V\u00e1zquez","year":"2024","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.tips.2026.08.005_bb0155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41421-020-0171-1","article-title":"A PROTAC peptide induces durable \u03b2-catenin degradation and suppresses Wnt-dependent intestinal cancer","volume":"6","author":"Liao","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.tips.2026.08.005_bb0160","doi-asserted-by":"crossref","first-page":"45138","DOI":"10.1021\/acsomega.4c06177","article-title":"Promising proteolysis-targeting chimera for mutant p53-R175H","volume":"9","author":"Zhuang","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.tips.2026.08.005_bb0165","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1038\/s41467-025-57823-5","article-title":"Identification of a non-inhibitory aptameric ligand to CRL2ZYG11B E3 ligase for targeted protein degradation","volume":"16","author":"Yang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.08.005_bb0170","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ccell.2019.10.002","article-title":"A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo","volume":"36","author":"Bai","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tips.2026.08.005_bb0175","doi-asserted-by":"crossref","first-page":"16704","DOI":"10.1021\/acs.jmedchem.6c00367","article-title":"GID4-recruiting PROTACs for BRD4 degradation overcome resistance driven by CRBN and VHL deficiency","volume":"69","author":"Tang","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2026.08.005_bb0180","doi-asserted-by":"crossref","first-page":"13529","DOI":"10.1073\/pnas.1917969117","article-title":"MAML1\/2 promote YAP\/TAZ nuclear localization and tumorigenesis","volume":"117","author":"Kim","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2026.08.005_bb0185","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ccell.2021.06.016","article-title":"Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP\/TEAD activity","volume":"39","author":"Pearson","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tips.2026.08.005_bb0190","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature11693","article-title":"Restriction of intestinal stem cell expansion and the regenerative response by YAP","volume":"493","author":"Barry","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.tips.2026.08.005_bb0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tips.2026.08.005_bb0200","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","article-title":"The 60-year evolution of lipid nanoparticles for nucleic acid delivery","volume":"23","author":"Cullis","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2026.08.005_bb0205","doi-asserted-by":"crossref","first-page":"0035","DOI":"10.34133\/bmef.0035","article-title":"Intracellular protein delivery: approaches, challenges, and clinical applications","volume":"5","author":"Chan","year":"2024","journal-title":"BME Front."},{"key":"10.1016\/j.tips.2026.08.005_bb0210","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1038\/s41467-024-49678-z","article-title":"Enhancing extracellular vesicle cargo loading and functional delivery by engineering protein-lipid interactions","volume":"15","author":"Peruzzi","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.08.005_bb0215","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s11095-023-03486-0","article-title":"Strategies to improve the physicochemical properties of peptide-based drugs","volume":"40","author":"Lee","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tips.2026.08.005_bb0220","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41573-024-01051-x","article-title":"Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics","volume":"23","author":"Carter","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2026.08.005_bb0225","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1208\/s12248-021-00642-5","article-title":"Immunogenicity risk assessment for multi-specific therapeutics","volume":"23","author":"Kroenke","year":"2021","journal-title":"AAPS J."},{"key":"10.1016\/j.tips.2026.08.005_bb0230","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40259-023-00641-2","article-title":"Reducing immunogenicity by design: approaches to minimize immunogenicity of monoclonal antibodies","volume":"38","author":"Harris","year":"2024","journal-title":"BioDrugs"},{"key":"10.1016\/j.tips.2026.08.005_bb0235","first-page":"202","article-title":"Active immunization targeting amyloid \u03b2 for the treatment of Alzheimer\u2019s disease","volume":"25","author":"Triplett","year":"2025","journal-title":"Neurodegener. Dis."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726002026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726002026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:06:41Z","timestamp":1790867201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614726002026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0165614726002026"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2026.08.005","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Midnolin-directed protein degradation beyond ubiquitin","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2026.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}